Estradiol-induced adult anovulatory syndrome in female C57BL/6J mice: age-like neuroendocrine, but not ovarian, impairments

• Published in: Biology of reproduction Vol. 30; no. 3; pp. 556 - 563
• Main Authors: MOBBS, C. V, FLURKEY, K, GEE, D. M, YAMAMOTO, K, SINHA, Y. N, FINCH, C. E
• Format: Journal Article
• Language: English
• Published: Madison, WI Society for the Study of Reproduction 01.04.1984
• Subjects: Animals; Biological and medical sciences; Castration; Epithelium - drug effects; Estradiol - analogs & derivatives; Estradiol - blood; Estradiol - pharmacology; Estrus - drug effects; Female; Fundamental and applied biological sciences. Psychology; Hormone metabolism and regulation; Luteinizing Hormone - blood; Mammalian female genital system; Mice; Mice, Inbred C57BL; Ovulation - drug effects; Pregnancy; Prolactin - blood; Vagina - drug effects; Vertebrates: reproduction; Hypothalamohypophysoovarian axis; Animal model; Vertebrata; Mammalia; Mouse; Rodentia; Estrogen; Sex steroid hormone
• ISSN: 0006-3363; 1529-7268
• DOI: 10.1095/biolreprod30.3.556

Long-term effects of elevated plasma estradiol (E2) on ovarian and neuroendocrine functions were examined in 4-month-old cycling female C57BL/6J mice injected s.c. with 0.2 or 0.05 mg estradiol valerate (EV), or oil. Within 7 days, EV-injected mice became permanently acyclic, exhibiting the persistent vaginal cornification (PVC) characteristic of reproductive senescence in rodents. Four months after injection, ovaries from EV-injected mice exhibited no corpora lutea, but ovulated in response to an injection of human chorionic gonadotropin (hCG) (as do older, spontaneously PVC mice). When grafted into young mice, ovaries from EV-injected mice supported as many estrous cycles as ovaries from oil-injected controls. EV did not alter the suppression of luteinizing hormone (LH) by E2, LH response to injected LH releasing hormone (LHRH), or plasma prolactin (Prl). However, EV-injected mice exhibited impairments in LH regulation similar to those seen in old, acyclic mice. Plasma LH 30 days after ovariectomy was 40% lower, and E2-induced LH surges were 60% lower, in EV-injected mice versus controls. Furthermore, EV-injected mice were unable to support estrous cycles given young ovarian grafts, in contrast to controls. Effects of sustained but physiological levels (15-20 pg/ml) of plasma E2, were examined in intact cycling mice given sham or E2 implants. Six weeks after implantation, the implants were removed; only 50% of the E2-implanted mice subsequently exhibited estrous cycles, compared with 100% of sham-implanted controls. Furthermore, those E2-implanted mice which did cycle had fewer cycles than controls.